Korean Market
EXCH
ROKIT HEALTHCARE
★

ROKIT HEALTHCARE to Pay 1.32 Billion Won Advance for FDA-Approved Raw Material Adinizer, Strengthening Supply Chain and Shareholder Value

 
OWNR
ROKIT HEALTHCARE
★

Non-registered Exec Lee Young-il Granted 20,000 Stock Options (Total 60,000)

 
OWNR
ROKIT HEALTHCARE
★

Sangmin Lee's stake in ROKIT HEALTHCARE drops to 0.14% (holdings unchanged)

 
OWNR
ROKIT HEALTHCARE
★

CEO Lee Min-gu's ownership drops from 0.67% to 0.42%; acquires 2,500 shares via stock purchase rights

 
OWNR
ROKIT HEALTHCARE
★

CEO Seokhwan Yoo's Stake Drops to 23.85% (Due to Increase in Total Shares, 3.79M Shares Under Lock-up)

 
OWNR
ROKIT HEALTHCARE
★

ROKIT HEALTHCARE Vice President Gil Yun-gi Reports Change in Holdings - Slight Increase in Common Shares

 
OWNR
ROKIT HEALTHCARE
★

President Dae-young Kim's stake drops from 0.40% to 0.25% due to increase in total shares outstanding

 
OWNR
ROKIT HEALTHCARE
★★

Largest Shareholder Stake Plunges from 42.83% to 25.97% Due to Increase in Total Shares Outstanding

 
PERI
ROKIT HEALTHCARE
★

ROKIT Healthcare: Q1 2026 Sales Up 118%, Massive 62.5B Won Fundraising and Subsidiary Nasdaq Listing

 
PERI
ROKIT HEALTHCARE
★

ROKIT HEALTHCARE Q1 2026 Revenue Surges 118% but Operating Loss Persists, Debt Ratio 936%

 
EXCH
ROKIT HEALTHCARE
★★★

ROKIT Healthcare Subsidiary ROKIT AMERICA Pursues Nasdaq Listing: $25M Public Offering